# Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin

> **NCT01069939** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 427 (actual)

## Conditions studied

- Prevention

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01069939
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 427 (ACTUAL)
- **Last updated:** 2012-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069939, "Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01069939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*